University of Rochester Adult HIV Therapeutic Strategies Network CRS

Location	Box 689 , 601 Elmwood Avenue Rochester, NY 14642 United States of America
CRS Coordinator	Susan Hulse susan_hulse@urmc.rochester.edu 585-275-0529
CRS Leader	Michael Keefer michael_keefer@urmc.rochester.edu 585-275-8058
Studies	A5128: US Genomic Sampling A5322: Long-Term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of Aging, HIV Infection and Inflammation (HAILO) A5324: A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification with Maraviroc and Dolutegravir with No Intensification or Intensification with Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV A5332: REPRIEVE Trial A5345: HIV Rebound & Control Biomarkers A5357: A Study of Long-Acting Cabotegravir Plus VRC01LS to Maintain Viral Suppression in HIV-1-Infected Adults A5360: MINMON Study-Monitoring SOF/VEL in Treatment Naïve, Chronic HCV Participants A5361s: Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE) A5369: p24CE Vaccine Study A5370: Anti-PD-1 Antibody in HIV-1 A5379: B-Enhancement of HBV vaccination in persons living with HIV (BEe-HIVe): Evaluation of HEPLISAV-B A5395: A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons with COVID-19